Cargando…

Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study

AIM: To characterize patients with neurogenic bladder (NGB), their treatment patterns, healthcare resource utilization, and associated costs based on records from a primary care database in the United Kingdom. METHODS: This was a retrospective, descriptive, observational study of anonymized data fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaggi, Ashley, Nazir, Jameel, Fatoye, Francis, Siddiqui, Emad, Choudhury, Nurul, Argoubi, Ramzi, Ali, Mahmood, de Ridder, Dirk, Drake, Marcus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Clinical Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850049/ https://www.ncbi.nlm.nih.gov/pubmed/30924184 http://dx.doi.org/10.1002/nau.23981

Ejemplares similares

Anticholinergic Burden and Associated Healthcare Resource Utilization in Older Adults with Overactive Bladder
por: Jaggi, Ashley, et al.
Publicado: (2021)

Real world treatment patterns in the neurogenic bladder population: a systematic literature review
por: Jaggi, Ashley, et al.
Publicado: (2017)

Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
por: Yeowell, Gillian, et al.
Publicado: (2018)

Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care
por: Ali, Mahmood, et al.
Publicado: (2019)

The role of botulinum toxin A in treating neurogenic bladder
por: Weckx, Filip, et al.
Publicado: (2016)

The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study
por: Ali, Mahmood, et al.
Publicado: (2021)

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK
por: Nazir, Jameel, et al.
Publicado: (2017)

Neurogenic Bladder
por: Dorsher, Peter T., et al.
Publicado: (2012)

Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database
por: Argoubi, Ramzi, et al.
Publicado: (2023)

Management of neurogenic bladder
por: Oh, Seung-June
Publicado: (2015)

Neuromodulation in neurogenic bladder
por: Sanford, Melissa T., et al.
Publicado: (2016)

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
por: Nazir, Jameel, et al.
Publicado: (2018)

Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome
por: Gevaert, Thomas, et al.
Publicado: (2011)

Neurogenic non-neurogenic bladder in childhood: complications and prognostic factors
por: Boussetta, Abir, et al.
Publicado: (2021)

Cost Effectiveness of Mirabegron Compared with Tolterodine Extended Release for the Treatment of Adults with Overactive Bladder in the United Kingdom
por: Aballéa, Samuel, et al.
Publicado: (2014)

Neurogenic bladder: etiology and assessment
por: Bauer, Stuart B.
Publicado: (2008)

The neurogenic bladder: medical treatment
por: Verpoorten, Carla, et al.
Publicado: (2008)

Neurogenic Bladder in Lyme Disease
por: Kim, Mi-hwa, et al.
Publicado: (2012)

The Management of the Pediatric Neurogenic Bladder
por: Sturm, Renea M., et al.
Publicado: (2016)

Augmentation cystoplasty in neurogenic bladder
por: Çetinel, Bülent, et al.
Publicado: (2016)

Pharmacotherapy for Pediatric Neurogenic Bladder
por: Kroll, Paweł
Publicado: (2017)

Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system
por: Powell, Charles R.
Publicado: (2016)

Botulinum Toxin-A Therapy in Pediatric Urology: Indications for the Neurogenic and Non-Neurogenic Neurogenic Bladder
por: Dyer, Lori, et al.
Publicado: (2009)

Neurogenic Inflammation of Guinea-Pig Bladder
por: Bjorling, D. E., et al.
Publicado: (1994)

Treatment of the neurogenic bladder in spina bifida
por: de Jong, Tom P. V. M., et al.
Publicado: (2008)

OnabotulinumtoxinA in the treatment of neurogenic bladder
por: Gulamhusein, Aziz, et al.
Publicado: (2012)

Urodynamic evaluation in pediatric neurogenic bladder.
por: Kim, K. M., et al.
Publicado: (1993)

Urinary tract infection in the neurogenic bladder
por: Vigil, Humberto R., et al.
Publicado: (2016)

Neurogenic mechanisms in bladder and bowel ageing
por: Ranson, Richard N., et al.
Publicado: (2015)

Nonsurgical Management of the Neurogenic Bladder in Children
por: Kryger, John
Publicado: (2008)

Management of vesicoureteral reflux in neurogenic bladder
por: Wu, Charlotte Q., et al.
Publicado: (2017)

Neurogenic bladder – concepts and treatment recommendations
por: Truzzi, José Carlos, et al.
Publicado: (2021)

Neurogenic Bladder: Epidemiology, Diagnosis, and Management
por: Panicker, Jalesh N.
Publicado: (2020)

Spontaneous Bladder Perforation in an Infant Neurogenic Bladder: Laparoscopic Management
por: Cabezalí Barbancho, Daniel, et al.
Publicado: (2013)

Association of bladder trabeculation and neurogenic bladder with spinal cord injury
por: Won, Yu Hui, et al.
Publicado: (2022)

Management of sphincter insufficiency in patients with neurogenic bladder and bladder augmentation
por: Taskinen, Seppo, et al.
Publicado: (2023)

Posterior Reversible Encephalopathy Syndrome after Augmentation Cystoplasty in a Child with Neurogenic Bladder
por: Magray, Mudasir Ahmad, et al.
Publicado: (2018)

Regenerative Medicine Strategies for Treating Neurogenic Bladder
por: Yoo, James J., et al.
Publicado: (2011)

Renal function in children with congenital neurogenic bladder
por: Olandoski, Karen Previdi, et al.
Publicado: (2011)

Patient reported outcome measures in neurogenic bladder
por: Clark, Roderick, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5go0f2402jnot9fkcso218ua8h